160 results
8-K
EX-99.1
EMMA
Emmaus Life Sciences, Inc.
14 Nov 23
Emmaus Life Sciences Reports Q3 2023 Financial Results
12:00am
feature derivative, partially offset by a $1.9 million decrease in foreign exchange loss compared to Q3 2022.
Net Income (Loss). For the quarter … , partially offset by the increase of $3.5 million in operating expenses and $1.5 million in other expenses.
Liquidity and Capital Resources
8-K
EX-99.1
EMMA
Emmaus Life Sciences, Inc.
14 Aug 23
Emmaus Life Sciences Reports Q2 2023 Financial Results
3:24pm
offset by a $0.5 million increase in interest expense compared to Q2 2022.
Net Loss. For the quarter, the company realized a net loss of $1.5 million … and diluted common shares for the six months ended June 30, 2022. The decrease was due to the increase in net revenues, partially offset
8-K
EX-99.1
EMMA
Emmaus Life Sciences, Inc.
15 May 23
Emmaus Life Sciences Reports Q1 2023 Financial Results and Provides Business Update
10:01am
a $4.1 million increase in gross profit, partially offset by a $2.2 million increase in operating expenses in 2023 compared to the same period in 2022
8-K
EX-99.1
y81x5y7
31 Mar 23
Emmaus Life Sciences Reports 2022 Financial Results and Provides Business Update
4:27pm
8-K
EX-99.1
58n3nk5bih h0za3r8
14 Nov 22
Emmaus Life Sciences Reports Q3 2022 Financial Results and Provides Business Update
6:24pm
8-K
EX-99.1
jmass
15 Aug 22
Emmaus Life Sciences Reports Q2 2022 Financial Results and Provides Business Update
5:18pm
8-K
EX-99.1
0isvta3o4o1
13 May 22
Emmaus Life Sciences Reports Q1 2022 Financial Results and Provides Business Update
6:07am
8-K
EX-99.1
yvtuy0x4
31 Mar 22
Emmaus Life Sciences Reports 2021 Financial Results and Provides Business Update
5:26pm